Valuation: LivaNova PLC

Market Cap 4.43B 3.97B 3.67B 3.33B 6.22B 421B 6.3B 44B 17.47B 220B 16.62B 16.27B 699B P/E 2026 *
20.1x
P/E 2027 * 24.2x
Enterprise Value 4.5B 4.04B 3.73B 3.38B 6.33B 428B 6.4B 44.74B 17.77B 224B 16.9B 16.54B 711B EV / Sales 2026 *
2.96x
EV / Sales 2027 * 2.66x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day-0.30%
1 week+0.84%
Current month+5.07%
1 month+4.89%
3 months-0.25%
6 months+26.76%
Current year+30.64%
1 week 78.35
Extreme 78.35
81.77
1 month 74.23
Extreme 74.23
81.77
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2024
Director of Finance/CFO 56 31/10/2020
Investor Relations Contact - 01/08/2022
Director TitleAgeSince
Director/Board Member 69 19/10/2015
Chairman 74 09/06/2021
Director/Board Member 62 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
15/9/26 Free

General Counsel

6,291 0.0114%
10/9/26 Sell

Director

-3,500 0.0064%
4/9/26 Sell

Director

-2,300 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%+0.84%+48.08%+70.33% 4.43B
-1.70%+0.63%-18.93%+11.04% 178B
-1.54%-0.98%-21.45%+15.09% 116B
-0.89%-0.72%-0.19%+35.32% 115B
-0.08%+4.52%-42.79%+7.95% 93.1B
-1.40%-5.21%-3.18%+73.40% 62.09B
+0.17%-0.34%+10.87%+84.40% 55.87B
-0.69%+0.63%+4.27%-22.48% 53.12B
-1.57%+0.60%-13.31%+43.41% 44.22B
-0.30%+2.54%-3.57%-9.21% 33.59B
Average -0.83%+2.13%-4.02%+30.92% 75.54B
Weighted average by Cap. -1.04%+2.36%-12.87%+24.51%

Financials

2026 *2027 *
Net sales 1.52B 1.37B 1.26B 1.14B 2.14B 145B 2.16B 15.12B 6.01B 75.78B 5.71B 5.59B 240B 1.63B 1.46B 1.35B 1.23B 2.29B 155B 2.32B 16.2B 6.43B 81.16B 6.12B 5.99B 257B
Net income 226M 203M 187M 170M 318M 21.49B 322M 2.25B 893M 11.26B 849M 831M 35.72B 187M 168M 155M 140M 263M 17.75B 266M 1.86B 738M 9.31B 702M 687M 29.51B
Net Debt 75M 67.31M 62.15M 56.36M 105M 7.12B 107M 745M 296M 3.73B 282M 276M 11.84B -85M -76.29M -70.44M -63.88M -119M -8.07B -121M -845M -335M -4.23B -319M -312M -13.42B
Projected Income Statement - Annual - LivaNova PLC
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
27/10/26 USD 80.38 -0.30% 383,597
26/10/26 USD 80.62 -0.35% 362,375
23/10/26 USD 80.90 -0.46% 572,063
22/10/26 USD 81.27 +3.61% 522,978
21/10/26 USD 78.44 -1.59% 556,324
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - LivaNova PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
80.38USD
Average target price
90.55USD
Spread / Average Target
+12.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LivaNova PLC
  1. Stock Market
  2. Stocks
  3. LIVN Stock